» Articles » PMID: 21213215

Chromatin-modifying Drugs Induce MiRNA-153 Expression to Suppress Irs-2 in Glioblastoma Cell Lines

Overview
Journal Int J Cancer
Specialty Oncology
Date 2011 Jan 8
PMID 21213215
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are noncoding RNAs that regulate gene expression by inhibiting translation or by promoting mRNA degradation. Previously, we established that microRNA-153 (miR-153) induces apoptosis by downregulating B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1) protein expression levels in glioblastoma cell line DBTRG-05MG. In our study, we show that ectopic expression of miR-153 also inhibits the protein kinase B (PKB/Akt) pathway via reducing the protein level of insulin receptor substrate-2 (Irs-2). Moreover, simultaneous treatment with the chromatin-modifying drugs 4-phenylbutyric acid and 5-aza-2'-deoxycytidine induces miR-153 expression to suppress Irs-2, Bcl-2 and Mcl-1 expressions, thus downregulating the survival but upregulating the apoptotic pathways, implying that tumor suppressor miR-153 is a dual life and death regulator.

Citing Articles

miRNA-mediated control of gephyrin synthesis drives sustained inhibitory synaptic plasticity.

Welle T, Rajgor D, Kareemo D, Garcia J, Zych S, Wolfe S EMBO Rep. 2024; 25(11):5141-5168.

PMID: 39294503 PMC: 11549329. DOI: 10.1038/s44319-024-00253-z.


miRNA-mediated control of gephyrin synthesis drives sustained inhibitory synaptic plasticity.

Welle T, Rajgor D, Garcia J, Kareemo D, Zych S, Gookin S bioRxiv. 2024; .

PMID: 38168421 PMC: 10760056. DOI: 10.1101/2023.12.12.570420.


MicroRNAs as potential diagnostic markers of glial brain tumors.

Sufianov A, Begliarzade S, Ilyasova T, Xu X, Beylerli O Noncoding RNA Res. 2022; 7(4):242-247.

PMID: 36203525 PMC: 9519791. DOI: 10.1016/j.ncrna.2022.09.008.


A comprehensive review on miR-153: Mechanistic and controversial roles of miR-153 in tumorigenicity of cancer cells.

Yousefnia S Front Oncol. 2022; 12:985897.

PMID: 36158686 PMC: 9500380. DOI: 10.3389/fonc.2022.985897.


Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer.

Sassu C, Palaia I, Boccia S, Caruso G, Perniola G, Tomao F Int J Mol Sci. 2021; 22(24).

PMID: 34948446 PMC: 8707281. DOI: 10.3390/ijms222413650.